{
    "2019-02-13": [
        [
            {
                "time": "",
                "original_text": "【中信建投医药】医药行业周报：业绩分化明显，把握投资机会",
                "features": {
                    "keywords": [
                        "医药行业",
                        "业绩分化",
                        "投资机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物2月投资策略及年报前瞻：期待年报报喜，关注政策变化",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "年报",
                        "政策变化"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}